Personalis (NASDAQ:PSNL) Sets New 12-Month High – Still a Buy?

Personalis, Inc. (NASDAQ:PSNL) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $14.18 and last traded at $13.90, with a volume of 461910 shares traded. The stock had previously closed at $13.40.

Analyst Upgrades and Downgrades

PSNL has been the subject of several recent research reports. Morgan Stanley reduced their price target on Personalis from $10.00 to $9.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 12th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Personalis in a research report on Tuesday, April 21st. BTIG Research dropped their price objective on Personalis from $13.00 to $11.00 and set a “buy” rating on the stock in a research note on Monday, May 11th. Finally, Wall Street Zen downgraded Personalis from a “hold” rating to a “sell” rating in a report on Saturday, June 13th. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Personalis has an average rating of “Moderate Buy” and an average target price of $11.00.

Personalis Trading Up 3.1%

The firm has a market capitalization of $1.45 billion, a price-to-earnings ratio of -13.56 and a beta of 2.28. The company’s 50 day moving average is $8.69 and its 200-day moving average is $8.34.

Personalis (NASDAQ:PSNL) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.06). The business had revenue of $15.47 million for the quarter, compared to the consensus estimate of $14.48 million. Personalis had a negative return on equity of 43.52% and a negative net margin of 148.11%. Research analysts expect that Personalis, Inc. will post -1.06 EPS for the current year.

Insider Activity at Personalis

In other news, CFO Aaron Tachibana sold 51,251 shares of Personalis stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $13.18, for a total transaction of $675,488.18. Following the completion of the transaction, the chief financial officer directly owned 198,833 shares in the company, valued at approximately $2,620,618.94. The trade was a 20.49% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Christopher M. Hall sold 100,000 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $13.15, for a total value of $1,315,000.00. Following the transaction, the chief executive officer directly owned 235,986 shares in the company, valued at $3,103,215.90. The trade was a 29.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 335,032 shares of company stock valued at $4,091,929 over the last quarter. 4.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Personalis

Several large investors have recently modified their holdings of PSNL. Aberdeen Group plc increased its stake in shares of Personalis by 36.1% during the fourth quarter. Aberdeen Group plc now owns 3,249,895 shares of the company’s stock worth $25,869,000 after purchasing an additional 861,948 shares during the period. Oracle Investment Management Inc. acquired a new position in Personalis in the 3rd quarter valued at $1,496,000. ARK Investment Management LLC increased its position in Personalis by 11.3% during the 3rd quarter. ARK Investment Management LLC now owns 7,910,191 shares of the company’s stock worth $51,574,000 after buying an additional 802,268 shares during the period. Howland Capital Management LLC lifted its holdings in shares of Personalis by 65.5% during the fourth quarter. Howland Capital Management LLC now owns 547,115 shares of the company’s stock worth $4,355,000 after buying an additional 216,442 shares in the last quarter. Finally, Next Century Growth Investors LLC bought a new stake in shares of Personalis in the fourth quarter valued at about $4,970,000. 61.91% of the stock is owned by institutional investors.

Personalis Company Profile

Personalis, Inc (NASDAQ: PSNL) is a clinical‐stage genomics company that develops and markets advanced next‐generation sequencing (NGS) services and assays designed to accelerate precision medicine. The Company’s core offering is the ImmunoID NeXT™ Platform, which combines comprehensive tumor profiling—including whole exome, transcriptome, and T‐cell receptor sequencing—with proprietary bioinformatics to identify biomarkers and guide immuno‐oncology research. Personalis serves biopharmaceutical companies, academic institutions, and clinical research organizations seeking in‐depth insights into cancer, autoimmune diseases and other complex conditions.

In addition to its flagship ImmunoID NeXT™ Platform, Personalis offers a suite of customizable sequencing assays for biomarker discovery, clinical trial support and companion diagnostic development.